Appeals Court Reinstates In-Person Dispensing for Mifepristone and Blocks Mail Access
Mifepristone In-Person Dispensing Requirement·May 1 – May 2, 2026
3 hours ago
Appeals Court Reinstates In-Person Dispensing for Mifepristone and Blocks Mail Access
The 5th U.S. Circuit Court of Appeals issued a nationwide ruling that requires mifepristone to be dispensed in person. This decision blocks patients from receiving the abortion pill through the mail or telehealth services. The court's action reverses previous FDA policies that allowed for remote prescriptions and delivery. By reinstating these requirements, the court has limited how the drug can be distributed across the United States.
The ruling specifically targets the use of telemedicine for medication abortions. It mandates that patients must visit a clinic or hospital to get the medication rather than having it shipped to their homes. This legal move challenges the FDA's regulatory power over how medications are safely distributed to the public.
Appeals court ends nationwide access to abortion pills via telehealth and mailAppeals court blocks mail-order mifepristone, restricting abortion access nationwideCourt restricts abortion access across U.S. by blocking the mailing of mifepristone
News
Federal appeals court blocks mailing of abortion pills in ruling with nationwide effect
Appeals court limits abortion pill access nationwide
Appeals Court Curtails Access to Mail-Order Abortion Pills
Appeals court blocks mail-order mifepristone, restricting abortion access nationwide
Appeals court limits access to abortion drug by telemedicine
Court restricts abortion access across the US by blocking the mailing of mifepristone - The Boston Globe
Analysis generated by AI. Always verify with official sources.